The identification of CCL18 as biomarker of disease activity in localized scleroderma

J. S. Mertens*, E. M.G.J. de Jong, L. L. van den Hoogen, J. Wienke, R. M. Thurlings, M. M.B. Seyger, E. P.A.H. Hoppenreijs, C. A. Wijngaarde, I. M.J.J. van Vlijmen-Willems, E. van den Bogaard, B. Giovannone, F. van Wijk, A. van Royen-Kerkhof, W. Marut, T. R.D. Radstake

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'The identification of CCL18 as biomarker of disease activity in localized scleroderma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology